Frontlight ResearchEarly access
Liver and biliary tract cancer trials in China
621 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleEfficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors
- Where
- Yangzhou
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Northern Jiangsu People's Hospital
See details and how to joinNCT07337460 - Phase 2Not yet taking people in ChinaExploration of Sintilimab + Bevacizumab + AG Chemotherapy as First-Line Treatment for Unresectable Advanced/Metastatic Cholangiocarcinoma
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 25
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07328802 - Phase 3Not yet taking people in ChinaEfficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations
- Where
- Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Nanchang, Nanjing, Shanghai, Wuhan, Zhengzhou
- Age
- 18 years and over
- People
- 138
- Run by
- TransThera Sciences (Nanjing), Inc.
See details and how to joinNCT07328919 - No phaseTaking peopleImpact of Emotional Disorders on Response to Immune Checkpoint Inhibitor Therapy in Liver Cancer
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 651
- Run by
- Tongji Hospital
See details and how to joinNCT07325565 - Phase 2Taking peopleABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou, Guilin, Guiyang, Hangzhou, Harbin, Hefei, Jinan, Jining, Liuzhou, Luoyang, Mianyang, Nanchang, Nanjing, Nanning, Nantong, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan, Xi’an, Xuzhou, Yinchuan, Zhengzhou
- Age
- 18 years and over
- People
- 141
- Run by
- Abbisko Therapeutics Co, Ltd
See details and how to joinNCT07327034 - Phase 2Taking peopleNWRD06 DNA Plasmid for HCC After Curative Resection.
- Where
- Beijing, Hangzhou, Harbin
- Age
- 18 years to 65 years
- People
- 30
- Run by
- Newish Technology (Beijing) Co., Ltd.
See details and how to joinNCT07324304 - Phase 2Not yet taking people in ChinaIvarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical Study
- Where
- Chongqing
- Age
- 18 years to 75 years
- People
- 65
- Run by
- First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT07324473 - Phase 1/2Taking peopleStudy of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT06938880 - Phase 2Taking peopleβ-alanine in the Treatment of Advanced Hepatocellular Carcinoma
- Where
- Beijing, Nanjing, Xuzhou
- Age
- 18 years to 75 years
- People
- 158
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07317414 - Phase 2/3Taking peopleHMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma
- Where
- Beijing
- Age
- 18 years and over
- People
- 235
- Run by
- Hutchmed
See details and how to joinNCT04353375 - No phaseTaking peopleTarget-specific immunoPET Imaging of Digestive System Carcinoma
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 400
- Run by
- RenJi Hospital
See details and how to joinNCT06715839 - Phase 2Enrolling by invitationGemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 44
- Run by
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07310069 - Phase 2Taking peoplePhase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 75
- Run by
- Zhejiang Hisun Pharmaceutical Co. Ltd.
See details and how to joinNCT07310173 - No phaseNot yet taking people in ChinaEffect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma
- Where
- Lanzhou, Tianjin, Xi’an
- Age
- 18 years to 90 years
- People
- 100
- Run by
- Hepatopancreatobiliary Surgery Institute of Gansu Province
See details and how to joinNCT03104569 - No phaseTaking peopleClinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
- Where
- Wuhan
- Age
- 18 years and over
- People
- 56
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07301814 - Early phase 1Taking peopleNIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 30
- Run by
- West China Hospital
See details and how to joinNCT07295262 - No phaseTaking peopleDiagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection
- Where
- Chengdu
- Age
- 18 years to 80 years
- People
- 20
- Run by
- West China Hospital
See details and how to joinNCT07295340 - Phase 1Taking peopleJMT106 Injection in the Treatment of Advanced Solid Tumors
- Where
- Zhejiang
- Age
- 18 years and over
- People
- 200
- Run by
- Shanghai JMT-Bio Inc.
See details and how to joinNCT07275073 - Phase 1/2Taking peopleMultimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 144
- Run by
- Tongji Hospital
See details and how to joinNCT07282184 - No phaseEnrolling by invitationSurvival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 729
- Run by
- Fujian Provincial Hospital
See details and how to joinNCT07290764 - No phaseTaking peopleAnti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA
- Where
- Shanghai
- Age
- 18 years to 90 years
- People
- 50
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07291063 - Phase 1/2Taking peoplePULSAR Combined With Immunotherapy and Chemotherapy
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Wang Xin
See details and how to joinNCT07291947 - Phase 3Taking peopleCamrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 326
- Run by
- Linhui Peng
See details and how to joinNCT07267806 - Phase 2/3Taking peopleThe Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD
- Where
- Shanghai
- Age
- 18 years and over
- People
- 20
- Run by
- Eastern Hepatobiliary Surgery Hospital
See details and how to joinNCT07285850 - No phaseTaking peopleAnti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC
- Where
- Shanghai
- Age
- 18 years to 90 years
- People
- 50
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06537908